High serum TNF-α level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells
- 1 November 2005
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 19 (6) , 347-355
- https://doi.org/10.1016/j.jdiacomp.2005.04.002
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 28 references indexed in Scilit:
- In vivo gene transfer of soluble TNF‐α receptor 1 alleviates myocardial infarctionThe FASEB Journal, 2002
- Increased proliferation of endothelial cells with overexpression of soluble TNF-α receptor I geneAtherosclerosis, 2002
- High-Density Lipoproteins Protect Endothelial Cells from Tumor Necrosis Factor-α-Induced ApoptosisBiochemical and Biophysical Research Communications, 2000
- Endothelial Dysfunction: Does It Matter? Is It Reversible?Journal of the American College of Cardiology, 1997
- Vascular endothelial dysfunctionProgress in Cardiovascular Diseases, 1997
- Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells.Journal of Clinical Investigation, 1996
- The pathogenesis of vascular complications of diabetes mellitus: one voice or many?European Journal of Clinical Investigation, 1996
- Tumor Necrosis Factor: Function, Release and ClearanceCritical Reviews in Immunology, 1996
- Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity.Journal of Clinical Investigation, 1994
- TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic TargetAnnual Review of Medicine, 1994